1887

Abstract

Abstract

Over the past several years the funding of stem cell research has often been justified on the grounds that it could serve as an engine of regional economic growth. To some degree, this is part of a larger trend, one that has placed biomedical research as a central component of many jurisdictions’ economic strategies. This has led to increasing pressure on researchers to build links with industry, to rapidly move their work to the clinic and to develop commercializable products. While there are undeniable benefits with this approach, it has also created some interesting policy challenges. In this presentation I will both review the nature and extent of the commercialization pressure and explore the related legal, ethical and social issues, including the possible adverse impact commercialization pressure may have on the research environment and the promotion of inappropriate 'hype'.

Loading

Article metrics loading...

/content/papers/10.5339/qproc.2012.stem.1.38
2012-02-01
2019-12-08
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/papers/10.5339/qproc.2012.stem.1.38
Loading
  • Received: 05 March 2012
  • Accepted: 28 March 2012
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error